Cargando…
A Polyamine-Deficient Diet Prevents Oxaliplatin-Induced Acute Cold and Mechanical Hypersensitivity in Rats
BACKGROUND: Oxaliplatin is an anticancer drug used for the treatment of advanced colorectal cancer, but it can also cause painful peripheral neuropathies. The pathophysiology of these neuropathies has not been yet fully elucidated, but may involve spinal N-methyl-D-aspartate (NMDA) receptors, partic...
Autores principales: | Ferrier, Jérémy, Bayet-Robert, Mathilde, Pereira, Bruno, Daulhac, Laurence, Eschalier, Alain, Pezet, Denis, Moulinoux, Jacques-Philippe, Balayssac, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813736/ https://www.ncbi.nlm.nih.gov/pubmed/24204988 http://dx.doi.org/10.1371/journal.pone.0077828 |
Ejemplares similares
-
Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet—NEUROXAPOL: protocol of a prospective, randomised, controlled, single-blind and monocentric trial
por: Balayssac, David, et al.
Publicado: (2015) -
Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors
por: Descoeur, Juliette, et al.
Publicado: (2011) -
Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup
por: Kerckhove, Nicolas, et al.
Publicado: (2019) -
Efficacy of donepezil for the treatment of oxaliplatin-induced peripheral neuropathy: DONEPEZOX, a protocol of a proof of concept, randomised, triple-blinded and multicentre trial
por: Kerckhove, Nicolas, et al.
Publicado: (2022) -
In-Depth Characterization of Somatic and Orofacial Sensitive Dysfunctions and Interfering-Symptoms in a Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mouse Model
por: Démosthènes, Amélie, et al.
Publicado: (2022)